Effects of Early Mobility Protocols in Cardiac ICU

September 12, 2023 updated by: Riphah International University

Effects of Early Mobilization on Functional Capacity, Physical Activity and Kinesiophobia in Post Coronary Artery Bypass Grafting

In this study the investigator aim to find the effects of early mobility on different physical activity protocols in post CABG patients. Physical activity, functional status, functional capacity, Kinesiophobia, ICU mortality, heart rate, blood pressure, oxygen saturation, length of hospital stay and sternal instability. To compare the physical activity protocol used by physical therapist.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Current study will compare two different early mobility protocols and will help in assessing best protocol to be use in cardiac ICU for better outcomes of patients.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Recruiting
        • Rehman Medical Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 40-70 years
  • Both Genders
  • Extubated patients with no Complication
  • Post CABG (Elective)
  • Vitally stable
  • 1st CABG
  • Selective CABG surgeries

Exclusion Criteria:

  • Post anesthesia Psychosis
  • Corrective surgeries
  • Post CABG Stroke
  • Infectious wound
  • Participants with a physical disability
  • Intra-aortic balloon pump (IABP)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Mobility out of Bed
Active upper limb exercises will be conducted (flexion-extension and adduction-abduction) of large joints (shoulder, elbow and wrist) Associated with upper limb exercises, patients will undergo a series of exercises ergometer with lower limb (LL). The mobilization will be conduct on a cycle ergometer in an active, lasting 20 minutes, divided into three steps: heat 5 minutes; 10 minutes of low-intensity exercise, with a speed of 30 revolutions per minute (rpm); and 5 minutes recovery. The patient remains in the supine position with the head of the bed elevated to 45 degrees, while the lower limbs will remain planned
Ankle pumps (5*2), knee extension (5*2), breathing exercises with elbow flexion and extension(5*2), spirometry and progressive early ambulation (from bed to wheelchair and wheelchair to standing and from standing to few steps), and conventional chest physical activity (5 minutes on precursor)
Experimental: Ergometry in Bed
Active upper limb exercises will be conducted (flexion-extension and adduction-abduction) of large joints (shoulder, elbow and wrist) Associated with upper limb exercises, patients will undergo a series of exercises ergometer with lower limb (LL). The mobilization will be conduct on a cycle ergometer in an active, lasting 20 minutes, divided into three steps: heat 5 minutes; 10 minutes of low-intensity exercise, with a speed of 30 revolutions per minute (rpm); and 5 minutes recovery. The patient remains in the supine position with the head of the bed elevated to 45 degrees, while the lower limbs will remain planned
Ankle pumps (5*2), knee extension (5*2), breathing exercises with elbow flexion and extension(5*2), spirometry and progressive early ambulation (from bed to wheelchair and wheelchair to standing and from standing to few steps), and conventional chest physical activity (5 minutes on precursor)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Status score Questionnaire
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Five item scale measures the physical performance of patients in ICU.The Functional Status Score for the Intensive Care Unit (FSS-ICU) is a 5-item performance-based measure that utilizes an 8 point, ordinal scale to measure physical function for patients in the intensive care unit setting.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
BAECK PHYSICAL ACTIVITY QUESTIONNAIRE
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Evaluates the physical activity over the past 12 months. The MBPAQ (BHPAQ) evaluates habitual physical activities in individuals. Activities are scored on a scale of 1-5. A score of 5 indicates the most activity and 1 indicates the least activity for each index.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
6 minute walk Test
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Sub-maximal test evaluates the aerobic endurance. The 6-minute walk test (6MWT) assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Tampa Scale of Kinesiophobia
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Evaluate the fear of movement during activity ,17 items a self-reporting questionnaire based on evaluation of fear of movement, fear of physical activity, and fear avoidance. Individual item scores range from 1-4, with the negatively worded items (4,8,12,16) having a reverse scoring (4-1). The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia. Changes will be measured at baseline and at completion of 4th week
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
STERNAL INSTABILITY SCALE:
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
The sternal instability scale (SIS) is a non-invasive manual assessment tool used to detect early bony non-union or instability.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
BORG RATING OF PERCEIVED EXERTION
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
The Borg RPE Scale is a 15-point scale (6 to 20) used to rate subjective experiences during physical exertion. This subjective load scale can help estimate load symptoms, such as the degree of exertion, the degree of load and fatigue.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Length of Hospital stay
Time Frame: Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)
Total number of days stay in hospital average of days in both group.
Pre Operative (Baseline), 1st Assessment (0 Week) and 2nd Assessment (4 week)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sumaiyah Obaid, MS, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Estimated)

September 30, 2023

Study Completion (Estimated)

October 1, 2023

Study Registration Dates

First Submitted

December 6, 2022

First Submitted That Met QC Criteria

August 31, 2023

First Posted (Actual)

September 8, 2023

Study Record Updates

Last Update Posted (Actual)

September 14, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • REC/01373 Sarmad

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on CABG

Clinical Trials on Mobility out of Bed

Subscribe